Jeffrey S. Heier - 02 Aug 2023 Form 4 Insider Report for OCULAR THERAPEUTIX, INC (OCUL)

Role
Director
Signature
/s/ Donald Notman, Attorney-in-Fact for Jeffrey S. Heier
Issuer symbol
OCUL
Transactions as of
02 Aug 2023
Transactions value $
$0
Form type
4
Filing time
18 Aug 2023, 21:45:39 UTC
Previous filing
16 Jun 2023
Next filing
04 Oct 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCUL Stock Option (Right to Buy) Award $0 +17.4K $0.00 17.4K 02 Aug 2023 Common Stock 17.4K $4.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the reporting person's continued service as a consultant to the Company, the option will vest over one year, with 1/12 of the shares underlying the option vesting monthly beginning on the one-month anniversary of the Vesting Commencement Date. The Vesting Commencement Date for this award is July 1, 2023.